Antiangiogenesis signals by endostatin - PubMed (original) (raw)
. 2001 Apr;15(6):1044-53.
doi: 10.1096/fj.99-1083com.
Affiliations
- PMID: 11292666
- DOI: 10.1096/fj.99-1083com
Antiangiogenesis signals by endostatin
M Shichiri et al. FASEB J. 2001 Apr.
Abstract
Endostatin is a potent endogenous angiogenesis inhibitor that induces regression of tumors in mice. Neither an extracellular receptor for endostatin nor intracellular signals that result in the regression of tumor vascular beds have been identified. We demonstrate that endostatin, but not angiostatin, at comparable concentrations to those used in in vivo animal trials, rapidly down-regulates many genes in exponentially growing endothelial cells. These include immediate early response genes, cell cycle-related genes, and genes regulating apoptosis inhibitors, mitogen-activated protein kinases, focal adhesion kinase, G-protein-coupled receptors mediating endothelial growth, a mitogenic factor, adhesion molecules, and cell structure components. Suppression of both apoptosis inhibitors and cell proliferation genes may have a limited contribution to the antiangiogenesis process because endostatin induces neither apoptosis nor growth inhibition, unless studied under reduced serum conditions. In contrast, the antimigratory effect of endostatin was rapid and potent even under serum-supplemented conditions. Endostatin caused gene suppression and migration arrest exclusively in endothelial cells, most profoundly in microvascular endothelial cells. The c-myc null fibroblasts obtained by targeted homologous recombination showed an attenuated migration rate compared with isogenic parental cells, whereas the introduction of the c-myc gene into endothelial cells abrogated the antimigratory effect of endostatin. Inhibition of E-box-driven transcription by overexpressing max or mad suppressed endothelial migration. Thus, rapid down-regulation of genes by endostatin neither restores proliferating endothelial cells to their resting states nor induces apoptosis; rather, it potently inhibits endothelial cell migration partly via suppression of c-myc expression.
Similar articles
- Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
Urbich C, Reissner A, Chavakis E, Dernbach E, Haendeler J, Fleming I, Zeiher AM, Kaszkin M, Dimmeler S. Urbich C, et al. FASEB J. 2002 May;16(7):706-8. doi: 10.1096/fj.01-0637fje. Epub 2002 Mar 12. FASEB J. 2002. PMID: 11978735 - Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L, Donnini S, Chillemi F, Giachetti A, Ziche M. Morbidelli L, et al. Clin Cancer Res. 2003 Nov 1;9(14):5358-69. Clin Cancer Res. 2003. PMID: 14614021 - Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways.
Eriksson K, Magnusson P, Dixelius J, Claesson-Welsh L, Cross MJ. Eriksson K, et al. FEBS Lett. 2003 Feb 11;536(1-3):19-24. doi: 10.1016/s0014-5793(03)00003-6. FEBS Lett. 2003. PMID: 12586331 - Endostatin action and intracellular signaling: beta-catenin as a potential target?
Dixelius J, Cross MJ, Matsumoto T, Claesson-Welsh L. Dixelius J, et al. Cancer Lett. 2003 Jun 30;196(1):1-12. doi: 10.1016/s0304-3835(03)00267-2. Cancer Lett. 2003. PMID: 12860282 Review. - Structure and function of collagen-derived endostatin inhibitors of angiogenesis.
Sasaki T, Hohenester E, Timpl R. Sasaki T, et al. IUBMB Life. 2002 Feb;53(2):77-84. doi: 10.1080/15216540211466. IUBMB Life. 2002. PMID: 12049199 Review.
Cited by
- Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy.
Mongiat M, Pascal G, Poletto E, Williams DM, Iozzo RV. Mongiat M, et al. Proteoglycan Res. 2024 Jul-Sep;2(3):e22. doi: 10.1002/pgr2.22. Epub 2024 Jun 29. Proteoglycan Res. 2024. PMID: 39184370 - Pericardial Adipose Tissue Thrombospondin-1 Associates With Antiangiogenesis in Ischemic Heart Disease.
Ahmed B, Farb MG, Karki S, D'Alessandro S, Edwards NM, Gokce N. Ahmed B, et al. Am J Cardiol. 2024 Jan 1;210:201-207. doi: 10.1016/j.amjcard.2023.09.104. Epub 2023 Oct 18. Am J Cardiol. 2024. PMID: 37863116 - The exploration of three different treatment models of osimertinib plus antiangiogenic agents in non-small cell lung cancer: A real-world study.
Feng Y, Huang L, Zhu H, Tang L, Hu X, Shi Y. Feng Y, et al. Thorac Cancer. 2022 Sep;13(18):2641-2649. doi: 10.1111/1759-7714.14603. Epub 2022 Aug 9. Thorac Cancer. 2022. PMID: 36082809 Free PMC article. - Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma.
Dituri F, Gigante G, Scialpi R, Mancarella S, Fabregat I, Giannelli G. Dituri F, et al. Cancers (Basel). 2022 Apr 9;14(8):1902. doi: 10.3390/cancers14081902. Cancers (Basel). 2022. PMID: 35454809 Free PMC article. Review. - Optimized Attenuated Salmonella Typhimurium Suppressed Tumor Growth and Improved Survival in Mice.
Liang K, Zhang R, Luo H, Zhang J, Tian Z, Zhang X, Zhang Y, Ali MK, Kong Q. Liang K, et al. Front Microbiol. 2021 Dec 23;12:774490. doi: 10.3389/fmicb.2021.774490. eCollection 2021. Front Microbiol. 2021. PMID: 35003007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources